Literature DB >> 9861363

Malaria diagnosis by the polymerase chain reaction: a field study in south-eastern Venezuela.

M Postigo1, A Mendoza-León, H A Pérez.   

Abstract

A polymerase chain reaction (PCR) method that amplifies genus- and species-specific sequences present within the small subunit of ribosomal ribonucleic acid (ssRNA) genes of the human malaria parasites was used for the diagnosis of malaria in south-eastern Venezuela. One hundred blood samples were submitted to deoxyribonucleic acid extraction, PCR amplification and electrophoretic analysis of the PCR products, and the results were compared to those of routine microscopical diagnosis. The sensitivity of PCR for detection of Plasmodium vivax and P. falciparum malaria was 99% and 100%, respectively. However, 6 patients (6%) harboured parasites undetected by microscopy. The PCR assay detected a high proportion of mixed infections: 29% (17/59) of the infections microscopically diagnosed as P. vivax were shown to be mixed infections of P. vivax and P. falciparum. Forty per cent (7/17) of the individuals with a missed P. falciparum infection had received chloroquine in the previous 30 d. These results suggest that, in places where transmission of both P. vivax and P. falciparum occurs, PCR detection of malaria parasites can be a very useful complement to microscopical diagnosis in order to ascertain the true incidence of each species and for the follow-up of patients after specific treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861363     DOI: 10.1016/s0035-9203(98)90893-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  12 in total

Review 1.  Why do we need to know more about mixed Plasmodium species infections in humans?

Authors:  Peter A Zimmerman; Rajeev K Mehlotra; Laurin J Kasehagen; James W Kazura
Journal:  Trends Parasitol       Date:  2004-09

2.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

3.  Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.

Authors:  Tatiana Voza; Ana M Vigário; Elodie Belnoue; Anne Charlotte Grüner; Jean-Christophe Deschemin; Michèle Kayibanda; Florian Delmas; Chris J Janse; Blandine Franke-Fayard; Andrew P Waters; Irène Landau; Georges Snounou; Laurent Rénia
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.

Authors:  D P Mason; F E McKenzie
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

5.  Detection of malaria infection in blood transfusion: a comparative study among real-time PCR, rapid diagnostic test and microscopy: sensitivity of Malaria detection methods in blood transfusion.

Authors:  Gholamreza Hassanpour; Mehdi Mohebali; Ahmad Raeisi; Hassan Abolghasemi; Hojjat Zeraati; Mohsen Alipour; Ebrahim Azizi; Hossein Keshavarz
Journal:  Parasitol Res       Date:  2011-01-08       Impact factor: 2.289

6.  Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis.

Authors:  Laurin J Kasehagen; Ivo Mueller; David T McNamara; Moses J Bockarie; Benson Kiniboro; Lawrence Rare; Kerry Lorry; Will Kastens; John C Reeder; James W Kazura; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

7.  Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?

Authors:  D P Mason; S Krudsood; P Wilairatana; P Viriyavejakul; U Silachamroon; W Chokejindachai; P Singhasivanon; S Supavej; F E McKenzie; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-03       Impact factor: 0.267

8.  Genetic polymorphisms influence Plasmodium ovale PCR detection accuracy.

Authors:  A Calderaro; G Piccolo; F Perandin; C Gorrini; S Peruzzi; C Zuelli; L Ricci; N Manca; G Dettori; C Chezzi; G Snounou
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

9.  Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen.

Authors:  J Russ Forney; Chansuda Wongsrichanalai; Alan J Magill; Leslie G Craig; Jeeraphat Sirichaisinthop; Christian T Bautista; R Scott Miller; Christian F Ockenhouse; Kent E Kester; Naomi E Aronson; Ellen M Andersen; Higinio A Quino-Ascurra; Carlos Vidal; Kimberly A Moran; Clinton K Murray; Caroline Cady DeWitt; D Gray Heppner; Kevin C Kain; W Ripley Ballou; Robert A Gasser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Real-time PCR assay and rapid diagnostic tests for the diagnosis of clinically suspected malaria patients in Bangladesh.

Authors:  Mohammad Shafiul Alam; Abu Naser Mohon; Shariar Mustafa; Wasif Ali Khan; Nazrul Islam; Mohammad Jahirul Karim; Hamida Khanum; David J Sullivan; Rashidul Haque
Journal:  Malar J       Date:  2011-06-26       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.